Literature DB >> 29157725

Nonsurgical lumbar radiculopathies treated with ultramicronized palmitoylethanolamide (umPEA): A series of 100 cases.

Domenico Chirchiglia1, Pasquale Chirchiglia2, Francesco Signorelli3.   

Abstract

In this clinical/observational study we have reported the administration of Palmitoylethanolamide (PEA) in patients suffering from radicular lumbar spinal pathology, who had no indication for surgical treatment. We analyzed a series of 100 cases retrospectively, all undergoing clinical and diagnostic investigations, which had shown the presence of abnormalities of the vertebral body and intervertebral discs, mainly degenerative, such as spondyloarthrosis, spondylo-discarthrosis, disc protrusion, excluding disc herniation, which fell within surgical cases. We then administered ultramicronized PEA (umPEA) to these patients, in combination with paracetamol and codeine, obtaining interesting results regarding the improvement of pain symptoms of the spine pathology, in the various checks carried out, through the administration of pain assessment scales. We also noted its safety due to the total absence of adverse effects. The obtained results encourage the use of PEA in degenerative spine pathologies.
Copyright © 2017 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Algometry; Degenerative spine diseases; Low back pain; Palmitoylethanolamide

Mesh:

Substances:

Year:  2017        PMID: 29157725     DOI: 10.1016/j.pjnns.2017.11.002

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  9 in total

Review 1.  An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.

Authors:  Stephen D Skaper; Laura Facci; Morena Zusso; Pietro Giusti
Journal:  Front Cell Neurosci       Date:  2018-03-21       Impact factor: 5.505

2.  Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review.

Authors:  Maria Beatrice Passavanti; Aniello Alfieri; Maria Caterina Pace; Vincenzo Pota; Pasquale Sansone; Giacomo Piccinno; Manlio Barbarisi; Caterina Aurilio; Marco Fiore
Journal:  Syst Rev       Date:  2019-01-08

3.  Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome.

Authors:  Domenico Chirchiglia; Pasquale Chirchiglia; Rosa Marotta; Luca Gallelli
Journal:  Int Med Case Rep J       Date:  2019-02-15

4.  Micronized Palmitoylethanolamide: A Post Hoc Analysis of a Controlled Study in Patients with Low Back Pain - Sciatica.

Authors:  Giorgio Cruccu; Giulia Di Stefano; Paolo Marchettini; Andrea Truini
Journal:  CNS Neurol Disord Drug Targets       Date:  2019       Impact factor: 4.388

5.  Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide.

Authors:  Alessia D'Aloia; Federica Arrigoni; Renata Tisi; Alessandro Palmioli; Michela Ceriani; Valentina Artusa; Cristina Airoldi; Giuseppe Zampella; Barbara Costa; Laura Cipolla
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

6.  Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies.

Authors:  Dena Zeraatkar; Matthew Adam Cooper; Arnav Agarwal; Robin W M Vernooij; Gareth Leung; Kevin Loniewski; Jared E Dookie; Muhammad Muneeb Ahmed; Brian Y Hong; Chris Hong; Patrick Hong; Rachel Couban; Thomas Agoritsas; Jason W Busse
Journal:  BMJ Open       Date:  2022-08-04       Impact factor: 3.006

Review 7.  Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence.

Authors:  Damiana Scuteri; Francesca Guida; Serena Boccella; Enza Palazzo; Sabatino Maione; Juan Francisco Rodríguez-Landa; Lucia Martínez-Mota; Paolo Tonin; Giacinto Bagetta; Maria Tiziana Corasaniti
Journal:  Pharmaceutics       Date:  2022-08-11       Impact factor: 6.525

8.  Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect.

Authors:  Stefania Petrosino; Marika Cordaro; Roberta Verde; Aniello Schiano Moriello; Gabriele Marcolongo; Carlo Schievano; Rosalba Siracusa; Fabiana Piscitelli; Alessio F Peritore; Rosalia Crupi; Daniela Impellizzeri; Emanuela Esposito; Salvatore Cuzzocrea; Vincenzo Di Marzo
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

Review 9.  Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?

Authors:  Giorgia Della Rocca; Davide Gamba
Journal:  Animals (Basel)       Date:  2021-03-29       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.